Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001172661-25-002401·Context Therapeutics Inc.
Schedule 13G ownership disclosure
Context Therapeutics, Inc.
Common Stock · CUSIP: 21077P108
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Great Point Partners, LLC
Shares: 4,683,711.00 · Class: 5.22%
- Dr. Jeffrey R. Jay, M.D.
Shares: 4,683,711.00 · Class: 5.22%
- Ms. Lillian Nordahl
Shares: 4,683,711.00 · Class: 5.22%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-002401
- Form type
- SCHEDULE 13G/A
- Filer
- Context Therapeutics Inc.
- CIK
- CIK 1842952
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership